PerkinElmer to Acquire Oxford Immunotec for ~$591M

January 8, 2021 Auto Bot Acquire, M&A, PerkinElmer 0

Shots:

  • PerkinElmer to acquire Oxford Immunotec for $22/ share with a premium of ~28.3% to the closing price/ share of $17.15 on Jan 5, 2021, making a total deal value $591M. The transaction is expected to be completed in H1’21
  • The acquisition allows the PerkinElmer to strengthen its portfolio of advanced infectious disease testing solutions to include tuberculosis detection for better serving across the globe
  • The deal will enable PerkinElmer to combine its channel expertise & workflow and testing capabilities with Oxford Immunotec’s proficiencies in T cell immunology with its test kits for latent tuberculosis

Click here ­to­ read full press release/ article | Ref: BusinessWire | Image: NB Herard

The post PerkinElmer to Acquire Oxford Immunotec for ~$591M first appeared on PharmaShots.